Principal Statistical Programmer - Genetic Medicines
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Principal Statistical Programmer to join our Statistical Programming team, supporting a study team across our clinical portfolio. In this role, you will provide programming leadership and support for processing clinical trial data, designing and testing program logic while ensuring consistent, high-quality documentation, all while collaborating with a multidisciplinary study team to support analysis and reporting through regulatory approval and beyond.
Job description
When & where
- Location: Warren, NJ or Cambridge, MA
- Work model/flexibility: onsite
Discover your role
- Support or lead programming and quality control of analysis datasets, tables, listings, and graphs
- Coordinate activities and communicate shifting timelines and milestones to the study team
- Create and maintain programming specifications for analysis datasets across studies
- Support creation and validation of submission requirements, including annotated CRFs and define documents
- Work within a multidisciplinary study team to provide timely, quality support through regulatory approval and launch
- Provide programming support for presentations and statistical ad hoc requests, assisting with more complex data as needed
- Participate in department working groups, contributing to tool development and process improvement
- Design and test program logic independently, maintaining documentation in a regulated environment
- Enjoy working independently while staying closely connected to a broader study team
- Communicate clearly and proactively, especially around shifting timelines
- Take pride in accuracy and consistency when documenting and maintaining code
- Think analytically and enjoy solving programming and data challenges
- Stay curious about process improvement and enjoy contributing ideas to working groups
- Adapt comfortably to ad hoc requests and evolving priorities from senior leadership
- Bring attention to detail and a quality mindset to regulated work
This role requires
- Master's degree with 3+ years of relevant experience
- Proven programming experience supporting clinical study data and analysis deliverables
- Strong documentation and quality control skills within a regulated environment
- Experience collaborating within a multidisciplinary study team
Requirements
- Master's degree with 3+ years of relevant experience
- Proven programming experience supporting clinical study data and analysis deliverables
- Strong documentation and quality control skills within a regulated environment
- Experience collaborating within a multidisciplinary study team
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.